Literature DB >> 32153770

Cytotoxic effect of silica nanoparticles against hepatocellular carcinoma cells through necroptosis induction.

Yuexiang Niu1, Engong Tang1, Qingan Zhang1.   

Abstract

Hepatocellular carcinoma (HCC) is a common cancer that affects people worldwide with high morbidity and mortality, and its resistance to current chemotherapeutic drugs is a serious concern. Cytotoxicity of silica nanoparticles (Nano-SiO2) towards cancer cells has been reported previously, but the specific mechanism is not fully clear. In this study, Nano-SiO2 showed a remarkable cytotoxic effect against HCC cells, regardless of whether the cells were drug resistant or not. Further study showed that Nano-SiO2 treatment leads to cell cycle arrest, apoptosis enhancement and necroptosis induction in the HCC cells. RNA-seq data, together with bioinformatics analysis, revealed that a series of genes involved in cancer cell death could be regulated by Nano-SiO2, among which ZBP-1 was up-regulated the most by Nano-SiO2 treatment. The siRNA based experiments demonstrated that ZBP-1 might play a key role in mediating Nano-SiO2 cytotoxic functions against HCC cells. These results have evidently signified the anti-tumor potential of Nano-SiO2 in the treatment of HCC. This journal is © The Royal Society of Chemistry 2019.

Entities:  

Year:  2019        PMID: 32153770      PMCID: PMC7021192          DOI: 10.1039/c9tx00240e

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  25 in total

1.  Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 cell line.

Authors:  Jacques-Aurélien Sergent; Vincent Paget; Sylvie Chevillard
Journal:  Ann Occup Hyg       Date:  2012-02-29

2.  Expression and significance of tumor-related genes in HCC.

Authors:  Zi-Li Lü; Dian-Zhong Luo; Jian-Ming Wen
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Shikonin Induced Necroptosis via Reactive Oxygen Species in the T-47D Breast Cancer Cell Line.

Authors:  Zahra Shahsavari; Fatemeh Karami-Tehrani; Siamak Salami
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.

Authors:  M Hinz; D Krappmann; A Eichten; A Heder; C Scheidereit; M Strauss
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 5.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

6.  Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.

Authors:  Wu Chen; Wen Yang; Pengyu Chen; Yongzhuo Huang; Feng Li
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-16       Impact factor: 9.229

7.  Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.

Authors:  K Haselsberger; D C Peterson; D G Thomas; J L Darling
Journal:  Anticancer Drugs       Date:  1996-05       Impact factor: 2.248

Review 8.  Role of microRNAs in the development of hepatocellular carcinoma and acquired drug resistance.

Authors:  Lucas Tricoli; Suresh Niture; Uche Chimeh; Deepak Kumar
Journal:  Front Biosci (Landmark Ed)       Date:  2019-01-01

9.  Toxicity of silica nanoparticles depends on size, dose, and cell type.

Authors:  In-Yong Kim; Elizabeth Joachim; Hyungsoo Choi; Kyekyoon Kim
Journal:  Nanomedicine       Date:  2015-03-25       Impact factor: 5.307

10.  Combined Effect of Silica Nanoparticles and Benzo[a]pyrene on Cell Cycle Arrest Induction and Apoptosis in Human Umbilical Vein Endothelial Cells.

Authors:  Collins Otieno Asweto; Jing Wu; Hejing Hu; Lin Feng; Xiaozhe Yang; Junchao Duan; Zhiwei Sun
Journal:  Int J Environ Res Public Health       Date:  2017-03-09       Impact factor: 3.390

View more
  6 in total

1.  Submicron silica particles have cytotoxicities on hepatocellular carcinoma, non-small cell lung cancer and breast cancer by unified regulating the XLOC_001659/miR-98-5p/MAP3K2-mediated pathway.

Authors:  Jingdong Shi; Yukun Ci; Ying Zheng; Wenhui Chen; Xi Chen
Journal:  Toxicol Res (Camb)       Date:  2021-07-22       Impact factor: 2.680

Review 2.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

3.  Functionalized Mesoporous Silica as Doxorubicin Carriers and Cytotoxicity Boosters.

Authors:  Carmen Racles; Mirela-Fernanda Zaltariov; Dragos Peptanariu; Tudor Vasiliu; Maria Cazacu
Journal:  Nanomaterials (Basel)       Date:  2022-05-26       Impact factor: 5.719

Review 4.  Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.

Authors:  Xuan Wang; Peng Hua; Chengwei He; Meiwan Chen
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

5.  Global Proteomics to Study Silica Nanoparticle-Induced Cytotoxicity and Its Mechanisms in HepG2 Cells.

Authors:  Sun Young Lee; In Young Kim; Min Beom Heo; Jeong Hee Moon; Jin Gyeong Son; Tae Geol Lee
Journal:  Biomolecules       Date:  2021-03-02

Review 6.  Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.

Authors:  Anita Bakrania; Gang Zheng; Mamatha Bhat
Journal:  Pharmaceutics       Date:  2021-12-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.